RecruitingNot ApplicableNCT05776316

Harm Reduction Services

Culturally Response Integrated Harm Reduction Services for Black and Latinx People Who Use Drugs


Sponsor

NYU Langone Health

Enrollment

200 participants

Start Date

Nov 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • at least 18 years of age
  • self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria
  • English or Spanish speaking
  • able to provide informed consent.

Exclusion Criteria4

  • inability to provide informed consent or participate in the study procedures as proposed in the consent
  • active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder)
  • an unwillingness to be randomized.
  • are prisoners

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALIntegrated Harm Reduction Intervention (IHRI)

8-week program targeting areas rooted in the 8 principles of harm reduction. Includes weekly education lessons and informed referrals to social service organizations.


Locations(3)

Yale University

New Haven, Connecticut, United States

NYU Langone Health

New York, New York, United States

Nathan Kline Institute

Orangeburg, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05776316


Related Trials